AKKARAJU SRINIVAS 4
4 · Kalaris Therapeutics, Inc. · Filed Dec 22, 2025
Insider Transaction Report
Form 4
AKKARAJU SRINIVAS
Director10% Owner
Transactions
- Award
Common Stock
2025-12-22$10.00/sh+1,500,000$15,000,000→ 1,500,000 total(indirect: By Samsara Opportunity Fund, L.P.)
Holdings
- 11,448,081(indirect: By Samsara BioCapital, L.P.)
Common Stock
Footnotes (2)
- [F1]Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Samsara Opportunity GP and Dr. Akkaraju have voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of his or its respective pecuniary interest therein.
- [F2]Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.